DD vs DNTH · P/E 127, rev $12.39B vs rev $6.2M
Dupont De Nemours Inc (DD) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
DD currently screens at market cap $19.61B and trailing P/E 127.4. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the DD and DNTH stock pages for the full models.
Not investment advice.